SURG
Investment Highlights: The SurgePays portal has emerged as SURG’s revenue engine and its implementation is correlated with future catalysts. We believe that SURG is primed to move sharply higher in concert with a series of expected catalysts ahead
New stores are coming online, generating compounding and recurring revenue streams for Surge. Key metric: An estimated $1.5M in monthly revenue per 1000 stores, which should be continually replicated with greater sales penetration.
SurgePays, the Company’s innovative and industry-shifting merchant portal, is proving to be a valuable differentiator and business driver. As a primary component of the recent MOU signed with Pastime Foods, up to 40,000 new locations will use this SaaS portal (and become part of the SurgePays network) once the deal is closed and fully implemented.
Surge may be better positioned than any firm in the country to provide true, broad-based retail distribution of CBD-based partner-company products through its network. The producing firms are only now focused on distribution and SURG’s network represents the prime market for CBD-infused product companies. With access to a large network of C-stores and other outlets, we believe the Company will soon add popular, profitable, high-profile 3rd party offerings to its network in the near term. And…
…the pending signing of the Farm Bill, which legalizes hemp, has provided a major boost to the companies in the $22B industry, which should translate to SURG. Driven by revenue gains and milestone events, our target price remains $3.25.
New stores are coming online, generating compounding and recurring revenue streams for Surge. Key metric: An estimated $1.5M in monthly revenue per 1000 stores, which should be continually replicated with greater sales penetration.
SurgePays, the Company’s innovative and industry-shifting merchant portal, is proving to be a valuable differentiator and business driver. As a primary component of the recent MOU signed with Pastime Foods, up to 40,000 new locations will use this SaaS portal (and become part of the SurgePays network) once the deal is closed and fully implemented.
Surge may be better positioned than any firm in the country to provide true, broad-based retail distribution of CBD-based partner-company products through its network. The producing firms are only now focused on distribution and SURG’s network represents the prime market for CBD-infused product companies. With access to a large network of C-stores and other outlets, we believe the Company will soon add popular, profitable, high-profile 3rd party offerings to its network in the near term. And…
…the pending signing of the Farm Bill, which legalizes hemp, has provided a major boost to the companies in the $22B industry, which should translate to SURG. Driven by revenue gains and milestone events, our target price remains $3.25.
